Literature DB >> 3802691

Hypoalbuminaemia and naproxen pharmacokinetics in a patient with rheumatoid arthritis.

F A Van den Ouweland, F W Gribnau, Y Tan, C A Van Ginneken, L B Van de Putte.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3802691     DOI: 10.2165/00003088-198611060-00007

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  12 in total

1.  THE MECHANISM OF HYPOALBUMINEMIA IN RHEUMATOID ARTHRITIS.

Authors:  P WILKINSON; R JEREMY; F P BROOKS; J L HOLLANDER
Journal:  Ann Intern Med       Date:  1965-07       Impact factor: 25.391

2.  Pharmacokinetics of naproxen overdoses.

Authors:  R Runkel; M D Chaplin; H Sevelius; E Ortega; E Segre
Journal:  Clin Pharmacol Ther       Date:  1976-09       Impact factor: 6.875

3.  Pharmacodynamics of 197Au and 195Au labeled aurothiomalate in blood. Correlation with course of rheumatoid arthritis, gold toxicity and gold excretion.

Authors:  N L Gottlieb; P M Smith; E M Smith
Journal:  Arthritis Rheum       Date:  1974 Mar-Apr

4.  Albumin metabolism in rheumatoid arthritis.

Authors:  F C Ballantyne; A Fleck; W C Dick
Journal:  Ann Rheum Dis       Date:  1971-05       Impact factor: 19.103

5.  Alteration of drug-protein binding in renal disease.

Authors:  M M Reidenberg; D E Drayer
Journal:  Clin Pharmacokinet       Date:  1984-01       Impact factor: 6.447

6.  Cell-bound gold (CBG) in patients treated with aurothioglucose and with auranofin. A comparison of different methods of determination.

Authors:  P L van Riel; F W Gribnau; L B van de Putte
Journal:  J Rheumatol       Date:  1983-08       Impact factor: 4.666

7.  Negligible excretion of unchanged ketoprofen, naproxen, and probenecid in urine.

Authors:  R A Upton; J N Buskin; R L Williams; N H Holford; S Riegelman
Journal:  J Pharm Sci       Date:  1980-11       Impact factor: 3.534

8.  Relationship of serum naproxen concentration to efficacy in rheumatoid arthritis.

Authors:  R O Day; D E Furst; S H Dromgoole; B Kamm; R Roe; H E Paulus
Journal:  Clin Pharmacol Ther       Date:  1982-06       Impact factor: 6.875

9.  Protein binding of tolmetin.

Authors:  M L Selley; B W Madsen; J Thomas
Journal:  Clin Pharmacol Ther       Date:  1978-12       Impact factor: 6.875

Review 10.  Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs.

Authors:  R K Verbeeck; J L Blackburn; G R Loewen
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447

View more
  3 in total

Review 1.  Choosing the right nonsteroidal anti-inflammatory drug for the right patient: a pharmacokinetic approach.

Authors:  N M Davies; N M Skjodt
Journal:  Clin Pharmacokinet       Date:  2000-05       Impact factor: 6.447

Review 2.  Naproxen. A reappraisal of its pharmacology, and therapeutic use in rheumatic diseases and pain states.

Authors:  P A Todd; S P Clissold
Journal:  Drugs       Date:  1990-07       Impact factor: 9.546

Review 3.  Clinical pharmacokinetics of naproxen.

Authors:  N M Davies; K E Anderson
Journal:  Clin Pharmacokinet       Date:  1997-04       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.